SCHEDULE OF OPTION ACTIVITY (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Oct. 31, 2025 |
Oct. 31, 2024 |
Oct. 31, 2023 |
|
| Equity [Abstract] | |||
| Number of Shares, Balance | 1,112,923 | 1,112,923 | |
| Weighted Average Exercise Price per Share, Balance | $ 10.84 | $ 10.84 | |
| Weighted Average Remaining Contractual Life (in years) | 4 years 7 months 20 days | 5 years 7 months 20 days | 6 years 7 months 20 days |
| Aggregate intrinsic value, Balance | $ 1,560,431 | $ 16,899,060 | |
| Number of Shares, Exercised | |||
| Weighted Average Exercise Price per Share, Exercised | |||
| Number of Shares, Granted | |||
| Weighted Average Exercise Price per Share, Granted | |||
| Number of Shares, Expired | |||
| Weighted Average Exercise Price per Share, Expired | |||
| Number of Shares, Forfeited | |||
| Weighted Average Exercise Price per Share, Forfeited | |||
| Number of Shares, Balance | 1,112,923 | 1,112,923 | 1,112,923 |
| Weighted Average Exercise Price per Share, Balance | $ 10.84 | $ 10.84 | $ 10.84 |
| Aggregate intrinsic value, Balance | $ 501,923 | $ 1,560,431 | $ 16,899,060 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|